For research use only. Not for therapeutic Use.
Landogrozumab (LY2495655) is an humanized anti-myostatin monoclonal antibody. Landogrozumab effectively improves muscle volume, hand grip strength and function. Landogrozumab can be used for the research of muscle wasting disease[1].
Landogrozumab (3 and 15 mg/kg; i.v. once) affects muscle mass of aged mice with duchenne muscular dystrophy[1].
| Catalog Number | I042223 |
| CAS Number | 1391726-30-9 |
| Purity | ≥95% |
| Reference | [1]. Muramatsu H, et al. Novel myostatin-specific antibody enhances muscle strength in muscle disease models. Sci Rep. 2021 Jan 25;11(1):2160. |
